skip navigation nih record
Vol. LVIII, No. 23
November 17, 2006
cover

previous story

next story



Three NIH’ers Elected to IOM

Dr. Raynard Kington, NIH deputy director
Dr. Paul Sieving, NEI director
Dr. H. Clifford Lane, director, Office of Clinical Research, NIAID
NIH’s new IOM members are (from top) Dr. Raynard Kington, NIH deputy director; Dr. Paul Sieving, NEI director; and Dr. H. Clifford Lane, director, Office of Clinical Research, NIAID

Three NIH employees are among the 65 new members recently elected to the Institute of Medicine, raising its total active membership to 1,501. They are: Dr. Raynard Kington, NIH deputy director; NEI director Dr. Paul Sieving; and Dr. H. Clifford Lane, director, Office of Clinical Research, NIAID.

“It is a great pleasure to welcome these [65] distinguished and influential individuals to the Institute of Medicine,” said IOM president Dr. Harvey Fineberg. “Members are elected through a highly selective process that recognizes people who have made major contributions to the advancement of the medical sciences, health care and public health. Election is considered one of the highest honors in the fields of medicine and health.”

Current active members elect new members from among candidates nominated for their professional achievement and commitment to service.

Kington, an expert on the role of social factors as determinants of health, has been principal deputy director of NIH since February 2003. “Raynard has been invaluable in helping to lead NIH during a time of great scientific opportunity and formidable management challenges,” said NIH director Dr. Elias Zerhouni. “It is gratifying to know that the IOM has recognized his important contributions to science and medicine.”

Sieving is an ophthalmologist who has made seminal contributions to understanding hereditary retinal neurodegenerations and has explored therapy strategies to rescue rodent models and human blinding degenerative retinopathies known as retinitis pigmentosa (RP). He led the first human clinical therapy trial of a neurotrophic factor for RP, which was reported in 2006.

Lane is a pioneer in the study of the pathogenesis and treatment of HIV infection, including his groundbreaking work using interleukin-2 to reconstitute the immune systems of HIV-infected individuals. He has been a principal investigator on more than 30 studies in the U.S. and abroad and was the first to conduct a clinical trial of an AIDS vaccine in the U.S.

Established in 1970 by the National Academy of Sciences, the IOM has become recognized as a national resource for independent, scientifically informed analysis and recommendations on issues related to human health. NIH Record Icon

back to top of page